Thrombocytopenia after high-dose chemotherapy and autologous stem cell transplantation: An unresolved problem and possible approaches to resolve it

Journal of Hematotherapy and Stem Cell Research

Volumn 5, Issue 4, 1996, Pages 407-414

  Hassan, H T ^a   Zander, A R ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CD34 ANTIGEN; CYTOKINE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEMOPOIETIC GROWTH FACTOR; INTERLEUKIN 1; INTERLEUKIN 11; INTERLEUKIN 3; INTERLEUKIN 6; THROMBOPOIETIN;

ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; AUTOTRANSPLANTATION; CANCER PATIENT; CLINICAL TRIAL; COLONY FORMING UNIT GM; DRUG MEGADOSE; HUMAN; MEGAKARYOPOIESIS; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; THROMBOCYTOPENIA;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLOOD CELL COUNT; BONE MARROW; CLINICAL TRIALS, PHASE I; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEMATOPOIESIS; HEMATOPOIETIC CELL GROWTH FACTORS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; MEGAKARYOCYTES; NEOPLASMS; NEUTROPENIA; PLATELET COUNT; THROMBOCYTOPENIA; THROMBOPOIETIN; TIME FACTORS;

EID: 0029781549     PISSN: 15258165     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.1.1996.5.407     Document Type: Article

References (57)

1. Moore, M.A.S. Hematopoietic reconstitution: New approaches. Clin. Cancer Res. 1:3, 1995.
2. Spangrude, G.J. Biological and clinical aspects of hematopoietic stem cells. Annu. Rev. Med. 45:93, 1994.
3. Spangrude, G.J., Brooks, D.M. & Tumas, D.B. Long-term repopulation of irradiated mice with limiting numbers of purified hematopoietic stem cells: In vivo expansion of stem cell phenotype but not function. Blood 85:1006, 1995.
4. Hoffman, R. Regulation of megakaryocytopoiesis. Blood 74:1196, 1989.
5. Levine, R.F. The origin, development and regulation of megakaryocytes. Br. J. Haematol. 52:173, 1982.
6. Jiang, S., Levine, J.D., Fu, Y., et al. Cytokine production by primary bone marrow megakaryocytes. Blood 84:4151, 1994.
7. Hassan, H.T. & Zander, A.R. Editorial: Human normal and leukemic megakaryocytopoiesis. Cancer J. 8:170, 1995.
8. Zander, A.R., Lyding, J. & Bielack, S. Transplantation with blood stem cells. Blood Cells 17:301, 1991.
9. Gratwohl, A., Hermans, J. & Baldomero, H. Hematopoietic precursor cell transplants in Europe: Activity in 1994. Report from the EBMT 104, 1995.
10. Szer, J., Juttner, C.A., To, L.B., et al. Post-remission therapy for AML, with blood-derived stem cell transplantation. Results of a collaborative phase II trial. Int. J. Cell Cloning 10 (Suppl. 1):114, 1992.
11. Kessinger, A., Vose, J.M., Bierman, P.J., et al. High dose CBV and peripheral blood stem cell transplantation for patients with relapsed Hodgkin's lymphoma and bone marrow abnormalities. Int. J. Cell Cloning 10 (Suppl. 1):135, 1992.
12. Pettengell, R., Morgenstern, G.R., Woll, P.J., et al. Peripheral blood progenitor cell transplantation in lymphoma and leukemia using a single apheresis. Blood 82:3770, 1993.
13. Iacone, A., Pierelli, L., Quaglietta, A.M., et al. Survival after PBSC transplantation and comparison of engraftment speed with autologous and allogeneic BMT: Results of multicenter study. Int. J. Artif. Organs 16:45, 1993.
14. Fermand, J.P., Chevret, S., Ravaud, P., et al. High dose chemoradiotherapy and autologous blood stem cell transplantation in multiple myeloma: Results of a phase II trial involving 63 patients. Blood 82:2002, 1993.
15. Harousseau, J.L., Attal, M., Divine, M., et al. Comparison of ABMT and peripheral blood stem cell transplantation after first remission induction treatment in multiple myeloma. Bone Marrow Transplant. 15:963, 1995.
16. Reiffers, J., Faberes, C., Boiron, J.M. et al. Peripheral blood progenitor cell transplantation in 118 patients with hematological malignancies: Analysis of factors affecting the rate of engraftment. J. Hematother. 3:185, 1994.
17. Powles, R., Mehta, J., Singhal, S., et al. Autologous bone marrow or peripheral blood stem cell transplantation followed by maintenance chemotherapy for adult ALL in first remission: 50 cases from a single center. Bone Marrow Transplant. 16:241, 1995.
18. Nademanee, A., Sciecinski, I., Schmidt, G., et al. High-dose therapy followed by autologous peripheral blood stem cell transplantation for patients with Hodgkin's disease and non-Hodgkin's lymphoma using unprimed and G-CSF-mobilized peripheral blood stem cells. J. Clin. Oncol. 12:2176, 1994.
19. Faucher, C., le Corroller, A.G., Blaise, D., et al. Comparison of G-CSF-primed peripheral blood progenitor cells and bone marrow auto transplantation: Clinical assessment and cost-effectiveness. Bone Marrow Transplant. 14:895, 1994.
20. Chao, N.J., Schriber, J.R., Grimes, K., et al. G-CSF mobilized peripheral blood progenitor cells accelerate granulocyte and platelet recovery after high-dose chemotherapy. Blood 81:2031, 1993.
21. Bensinger, W., Singer, J., Appelbaum, F., et al. Autologous transplantation with peripheral blood mononuclear cells collected after administration of recombinant G-CSF. Blood 81:3156, 1993.
22. Bishop, M.R., Anderson, J.R., Jackson, J.D., et al. High-dose therapy and peripheral blood progenitor cell transplantation: Effects of human GM-CSF on the autograft. Blood 83:610, 1994.
23. Elias, A., Mazanet, R., Wheeler, C., et al. Peripheral blood progenitor cells: Two protocols using GM-CSF potentiated progenitor cell collection. In Autologous Bone Marrow Transplantation Proceedings of the 5th International Symposium, eds. Dicke, K.A., Armitrage, J.O. & Dicke-Evinger, M.J. University of Nebraska Medical Center, Nebraska, 1991, p. 875.
24. Kritz, A., Crown, J.P., Motzer, R.J., et al. Beneficial impact of peripheral blood progenitor cells in patients with metastatic breast cancer treated with high dose chemotherapy plus GM-CSF: A randomized trial. Cancer 71:2515, 1993.
25. Sureda, A., Brunet, S., Martinez, E., et al. A randomised study comparing cyclophosphamide versus cyclophosphamide + GM-CSF as mobilisation therapy for multiple myeloma patients. Bone Marrow Transplant. 15(Suppl. 1.):S74, 1995.
26. Takaue, Y., Kawano, Y., Abe, T., et al. Collection and transplantation of peripheral blood stem cells in very small children weighing 20 kg or less. Blood 86:372, 1995.
27. Negrin, R.S., Kusnierz-Glaz, C.R., Still, B.J., et al. Transplantation of enriched and purged peripheral blood progenitor cells from a single apheresis product in patients with non-Hodgkin's lymphoma. Blood 85:3334, 1995.
28. Tribalto, M., Papa, G., Coppetelli, U., et al. Treatment of multiple myeloma with autologous blood stem cell transplantation. Preliminary results of an Italian multicentric pilot study. Int. J. Artif. Organs 16:51, 1993.
29. Fukuda, M., Kojima, S., Matsumoto, K., et al. Autotransplantation of peripheral blood stem cells mobilised by chemotherapy and recombinant human G-CSF in childhood neuroblastoma and non-Hodgkin's lymphoma. Br. J. Haematol. 80:327, 1992.
30. Menichella, G., Pierelli, L., Vittori, M., et al. Five year experience in PBSC collection results of the Catholic University of Rome. Int. J. Artif. Organs 16:39, 1993.
31. Richel, D.J., van der Wall, E., Slaper, J., et al. Peripheral blood stem cell mobilization and transplantation in patients with malignant lymphomas and solid tumours. Int. J. Artif. Organs 16:71, 1993.
32. Beyer, J., Schwella, N., Zingsem, J., et al. Hematopoietic rescue after high-dose chemotherapy using autologous peripheral-blood progenitor cells or bone marrow: A comparison. J. Clin. Oncol. 13:1328, 1995.
33. Passos, J.L., Braine, H.G., Davis, J.M., et al. Predictive factors for peripheral-blood progenitor cell collections using a single large-volume leukapheresis after cyclophosphamide and G-CSF mobilisation. J. Clin. Oncol. 13:705, 1995.
34. Haas, R., Hohaus, S., Egerer, G., et al. Autologous blood stem cell transplantation in relapsed Hodgkin's disease. Int. J. Cell Cloning 10(Suppl. 1):138, 1992.
35. Ho, A.D., Gluck, S., Germond, C., et al. Optimal timing for collection of blood progenitor cells following induction chemotherapy and GM-CSF for autologous transplantation in advanced breast cancer. Bone Marrow Transplant. 6:269, 1992.
36. Bitran, J.D., Klein, L., Hanauer, S., et al. Mobilized peripheral blood progenitor cell collections utilising high dose cyclophosphamide and PIXY321. Proc. ASCO 14:265, 731A, 1995.
37. Schiller, G., Vescio, R., Freytes, C., et al. Transplantation of CD34 positive peripheral blood progenitor cells after high-dose chemotherapy for patients with advanced multiple myeloma. Blood 86:390, 1995.
38. Watts, M.J., Jones, H.M., Sullivan, A.M., et al. Accessory cells do not contribute to G-CSF or IL-6 production nor to rapid haematological recovery following peripheral blood stem cell transplantation. Br. J. Haematol. 91:767, 1995.
39. McQuaker I.G., Haynes, A.P., Owne, R.G., et al. Transplantation and engraftment of CD34+ blood stem cells for follicular lymphoma. Blood 86(Suppl.):232a, 915, 1995.
40. Koc, O.N., Gerson, S.L., Fox, R.M., et al. Infusion of CD34 enriched peripheral blood progenitor cells resulting in rapid engraftment after high-dose chemotherapy in patients with advanced lymphoma. Blood 86(Suppl.):233a, 917, 1995.
41. Hassan, H.T., Stockschläder, M., Krüger, W., et al. G-CSF administration following peripheral blood selected CD34 positive cells autologous transplantation accelerates haematological recovery after myeloablative therapy. Br. J. Haematol. 92:1027, 1996.
42. Widmer, L., Pichert, G., Jost, L.M., et al. Autologous transplantation of CD34+ selected and immunomagnetically purged hematopoietic progenitor cells mediates rapid hematological recovery after high-dose chemotherapy in patients with follicular lymphoma. Blood 86(Suppl.):231a, 914, 1995.
43. Raptis, G., Tiersten, A., Shapiro, F., et al. Rapid hematologic recovery following CD34+ selected versus unselected peripheral blood progenitor cell + filgrastim rescue of sequential high-dose chemotherapy in patients with metastatic breast cancer. Blood 86(Suppl.):403a, 1601, 1995.
44. Shpall, E.J., Jones, R.B., Bearman, S.I., et al. Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: Influence of CD34-positive peripheral blood progenitors and growth factors on engraftment. J. Clin. Oncol. 12:28, 1994.
45. Demeocq, F., Kanold, J., Berger, M., et al. Routine peripheral blood stem cells collection followed by CD34+ cell immunoselection is possible in children weighing 20 kg or less. Biological and clinical results. Blood 86(Suppl.):403a, 1599, 1995.
46. Tricot, G., Jagannath, S., Vesole, D., et al. Peripheral blood stem cell transplants for multiple myeloma: Identification of favorable variables for rapid engraftment in 225 patients. Blood 85:588, 1995.
47. Weaver, C.H., Hazelton, B., Birch, R., et al. An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy. Blood 86:3961, 1995.
48. Dreger, P., Klöss, M., Peterson, B., et al. Autologous progenitor cell transplantation: Prior exposure to stem cell-toxic drugs determines yield and engraftment of peripheral blood progenitor cell but not of bone marrow grafts. Blood 86:3970, 1995.
49. Link, H., Boogaerts, A.M., Carella, A.M., et al. A controlled trial of recombinant human GM-CSF after total body irradiation, high-dose chemotherapy and autologous BMT for acute lymphoblastic leukemia or malignant lymphoma. Blood 80:1288, 1992.
50. Advani, R., Chao, N.J., Horning, S.J., et al. GM-CSF as adjunct to autologous hematopoietic stem cell transplantation for lymphoma. Ann. Intern. Med. 116:183, 1992.
51. Khwaja, A., Linch, D.C., Goldstone, A.H., et al. Recombinant human GM-CSF after autologous BMT for malignant lymphoma: A British national lymphoma investigation double-blind, placebo-controlled trial. Br. J. Haematol. 82:317, 1992.
52. Gulati, S.C. & Bennett, C.L. GM-CSF as adjunct therapy in relapsed Hodgkin's disease. Ann. Intern. med. 116:177, 1992.
53. Nemunaitis, F.R., Appelbaum, J.M., Singer, J.W., et al. Phase I trial with recombinant human interleukin-3 in patients with lymphoma undergoing autologous bone marrow transplantation. Blood 82:3273, 1993.
54. Fay, J.W., Lazarus, H., Herzig, R., et al. Sequential administration of recombinant human interleukin-3 and GM-CSF after autologous bone marrow transplantation for malignant lymphoma: A phase I/II multicenter study. Blood 84:2151, 1994.
55. van Gameren, M.M., Willemse, P.H.B., Mulder, N.H., et al. Effects of recombinant human interleukin-6 in cancer patients: A phase I-II study. Blood 84:1434, 1994.
56. Gordon, M.S., Sledge, G.W., Battiato, L., et al. The in vivo effects of subcutaneously administered recombinant human interleukin-11 (neumega) in women with breast cancer. Blood 82:498a (abstract), 1993.
57. Basser, R., Clarke, K., Fox, R., et al. Randomised, double-blind, placebo-controlled phase I trial of pegylated megakaryocyte growth and development factor administered to patients with advanced cancer before and after chemotherapy - Early results. Blood 86(Suppl.):257a, 1014.